Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04403295 · ClinicalTrials.gov registry record · NA
Collaborative Specialty Care for Gulf War Illness
A NA study of Gulf War Illness, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 281
- Enrollment target
- 1
- Study location
NCT04403295: Active NA study of Gulf War Illness, sponsored by VA Office of Research and Development.
NCT04403295 is a NA study of Gulf War Illness that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 281 participants, above the 110-participant average among 14 other Gulf War Illness trials with a reported enrollment target (155% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04403295, a NA study of Gulf War Illness, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 281 participants
- Enrollment target
- 1
- Study location
Study Summary
Gulf War Veterans (GWVs) with Gulf War Illness (GWI) do not receive the care they should in the Veterans Affairs (VA). The investigators' data show 70% of GWVs with Gulf War Illness (GWI) do not receive treatment recommendations for their GWI and 78% are NOT very satisfied with their care. The quality of care GWVs receive must improve. VA and DoD have invested hundreds of millions of dollars to develop new treatments for GWVs, without effective delivery methods GWVs will not benefit. This study will be the first study to examine the best model of care to deliver treatments to GWVs with GWI. Determining the best model of care to translate research into practice is a key goal of the VA Gulf War Strategic Plan and a specific aim of this Request for Applications.
Primary Outcome
Pain disability will be assessed with the RMDS a 24 item scale of disability from pain. The RMDS is a core outcome measure for patients with chronic pain. A change of 2-3 points is considered clinically significant. Pain is present in 99% of GWVs with GWI and previous collaborative care trials in the VA have used this measure. Scores range from 0-24 with higher scores = greater disability.
Conditions Studied
Interventions
- BEHAVIORAL Collaborative Specialty Care
- BEHAVIORAL e-consultation
Study Locations (1)
New Jersey
- East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ - East Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 281 participants |
| Start Date | 2020-08-24 |
| Est. Completion | 2026-05-29 |
| Phase | NA |
What the registry record for NCT04403295 still lists
NCT04403295 is an interventional study that assigns participants to a tested intervention. The registered 281 participants enrollment target is mid-sized for trials with a published cap, above the 110-participant average among 14 other Gulf War Illness trials with a reported enrollment target (155% higher).
The record links to 1 condition, with Gulf War Illness appearing as the primary indexed condition, and to 2 interventions - of which Collaborative Specialty Care is the first listed.
NCT04403295 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT04403295 about?
NCT04403295 is a clinical study titled "Collaborative Specialty Care for Gulf War Illness". Gulf War Veterans (GWVs) with Gulf War Illness (GWI) do not receive the care they should in the Veterans Affairs (VA). The investigators' data show 70% of GWVs with Gulf War Illness (GWI) do not receive treatment recommendations for their GWI and 78% are NOT very satisfied with their care. The quali...
What is the current status of trial NCT04403295?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 281 participants. The study started on 2020-08-24. Estimated completion is 2026-05-29.
What conditions does trial NCT04403295 study?
This clinical trial studies the following conditions: Gulf War Illness.
What interventions are being tested in trial NCT04403295?
The interventions under investigation include: Collaborative Specialty Care (BEHAVIORAL), e-consultation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04403295?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04403295 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gulf War Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04403295's enrollment target sits among peer trials
281 2nd of 14 the highest of 14 other Gulf War Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gulf War Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nicotinamide Riboside Clinical Trial for GWI
RECRUITING · NA
-
Mechanisms of Gulf War Illness
RECRUITING · NA
-
Pilot Test of Apnea and Insomnia Relief for Veterans With Gulf War Illness
ACTIVE NOT RECRUITING · NA
-
Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWI
ACTIVE NOT RECRUITING · NA
-
Confirmation of Diet as a Treatment for Gulf War Illness
RECRUITING · Phase 3
-
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04521231 · 281 participants · Phase 1
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
- NCT06190730 · 281 participants · NA
REmote Symptom COllection to improVE postopeRative Care
- NCT02860364 · 282 participants · NA
Comparing Hypothermic Temperatures During Hemiarch Surgery
- NCT04867395 · 282 participants · NA
A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI